Simcere Pharmaceutical Group Liabilities:218.04M for Dec. 31, 2012
Simcere Pharmaceutical Group Liabilities Chart
Simcere Pharmaceutical Group Historical Liabilities DataPro Data Export
There is no data for the selected date range.
|Data for this Date Range|
|Dec. 31, 2012||218.04M|
|Sept. 30, 2012||217.76M|
|June 30, 2012||227.68M|
|March 31, 2012||257.94M|
|Dec. 31, 2011||265.96M|
|Sept. 30, 2011||235.96M|
|June 30, 2011||218.68M|
|March 31, 2011||203.78M|
|Dec. 31, 2010||202.59M|
|Sept. 30, 2010||171.20M|
|June 30, 2010||154.92M|
|March 31, 2010||164.16M|
|Dec. 31, 2009||169.52M|
About Total Liabilities
Liabilities are obligations of a company arising from past transactions or events which are expected to reduce assets when they are settled.
Note : This is a simple term, but fairly complex topic. A company's balance sheet is made up of three components : Assets, Liabilities, and Shareholder's Equity. Assets are equivalent to the sum of liabilities and shareholder's equity.
Let's say a company sells computers. The assets would be the machinery, the plant, the inventory, etc. the company. However, the value of these assets belong to who funded the company. Is the company backed by obligations/debt (loans from a bank, inventory from a supplier)? or ... The founder / common public's (shareholder's equity)? Most likely, a combination of both.
Simply, liabilities are the part of a company's assets that it has yet to repay back.
SCR Liabilities Benchmarks
SCR Liabilities Rankings
2554 of 8002
472 of 684 in Healthcare
50 of 68 in Drug Manufacturers - Specialty & Generic
SCR Liabilities Range, Past 5 Years
Street Insider May 9